Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of DTG/ABC/3TC in Pregnant Women with HIV
NCT02075593Phase 3Completed
- Sponsor
- ViiV Healthcare
- Start
- Dec 2014
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of dolutegravir in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Dec 2014; status: completed.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02075593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02075593.